- Personal FinanceCompare Online BrokersTop StocksAlternative Investing
- CryptoGet StartedNFTs
Adaptive Biotechnologies (NASDAQ:ADPT), Quotes and News Summary
Adaptive Biotechnologies (NASDAQ: ADPT)
Earnings
see more| Q2 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | (EXPECTED)2022-08-03 | ||||||
| REV | |||||||
| Q1 2022 | Est. | Actual | Surprise | ||||
|---|---|---|---|---|---|---|---|
| EPS | -0.450 | -0.440 | 0.0100 | ||||
| REV | 37.710M | 38.620M | 910.000K |
Analyst Ratings
see more| Date | Analyst Firm | Analyst Name | Action | Rating | Action Price | Prior Price | Target |
|---|
Adaptive Biotechnologies Questions & Answers
You can purchase shares of Adaptive Biotechnologies (NASDAQ: ADPT) through any online brokerage.
Other companies in Adaptive Biotechnologies’s space includes: Medpace Hldgs (NASDAQ:MEDP), 10x Genomics (NASDAQ:TXG), Codexis (NASDAQ:CDXS), Syneos Health (NASDAQ:SYNH) and Sotera Health (NASDAQ:SHC).
The latest price target for Adaptive Biotechnologies (NASDAQ: ADPT) was reported by Morgan Stanley on Friday, May 6, 2022. The analyst firm set a price target for 18.00 expecting ADPT to rise to within 12 months (a possible 131.36% upside). 4 analyst firms have reported ratings in the last year.
The stock price for Adaptive Biotechnologies (NASDAQ: ADPT) is $7.78 last updated May 19, 2022, 8:00 PM UTC.
There are no upcoming dividends for Adaptive Biotechnologies.
Adaptive Biotechnologies’s Q2 earnings are confirmed for Wednesday, August 3, 2022.
There is no upcoming split for Adaptive Biotechnologies.
Adaptive Biotechnologies is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.